Stocktoria
VIEMED HEALTHCARE, INC. VMD
Nasdaq · stock · Services-Misc Health & Allied Services, NEC · website · IPO 2017-12-22
VIEMED HEALTHCARE, INC. financials (annual)
Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $270.3M | $224.3M | $183.0M | $138.8M | $117.1M | $131.3M | $80.3M | $64.5M |
| Gross profit | $155.5M | $133.2M | $112.8M | $84.7M | $73.4M | $80.1M | $56.0M | $47.8M |
| R&D expense | $3.0M | $3.1M | $2.8M | $2.7M | $2.1M | $1.1M | $848,000 | $0 |
| SG&A expense | $121.4M | $106.2M | $87.9M | $68.2M | $54.9M | $52.8M | $41.4M | $34.3M |
| Operating income | $22.9M | $17.9M | $14.3M | $8.3M | $11.6M | $26.8M | $8.9M | $10.1M |
| Income tax | $6.4M | $4.8M | $4.1M | $2.8M | $3.4M | -$5.2M | $271,000 | $162,000 |
| Net income | $14.9M | $11.3M | $10.2M | $6.2M | $9.1M | $31.5M | $8.5M | $9.5M |
| EPS (diluted) | $0.37 | $0.28 | $0.25 | $0.16 | $0.22 | $0.78 | $0.21 | $0.24 |
| Operating cash flow | $51.9M | $39.1M | $45.2M | $27.7M | $22.5M | $35.1M | $19.1M | $22.4M |
| Free cash flow | $11.9M | $1.3M | $19.1M | $4.8M | $2.8M | $22.1M | $5.7M | $16.3M |
| Cash & equivalents | $13.5M | $17.5M | $12.8M | $16.9M | $28.4M | $31.0M | $13.4M | $10.4M |
| Inventory | $5.0M | $4.3M | $4.6M | $3.6M | $2.5M | $2.3M | $1.4M | $2.9M |
| Total assets | $199.2M | $177.1M | $154.9M | $117.0M | $118.0M | $112.6M | $82.6M | $53.7M |
| Total liabilities | $55.6M | $43.8M | $41.0M | $19.9M | $23.1M | $30.9M | $38.9M | $21.1M |
| Shareholders' equity | $143.5M | $133.3M | $113.9M | $97.1M | $94.8M | $81.7M | $43.7M | $32.6M |
Growth · year-over-year · Revenue CAGR 22.7%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | +20.5% | +22.5% | +31.8% | +18.6% | -10.8% | +63.6% | +24.5% | — |
| Net income growth | +32.6% | +10.0% | +64.6% | -31.8% | -71.1% | +269.9% | -10.3% | — |
| EPS growth | +32.1% | +12.0% | +56.2% | -27.3% | -71.8% | +271.4% | -12.5% | — |
| Free cash flow growth | +805.2% | -93.1% | +294.2% | +76.3% | -87.5% | +287.0% | -64.9% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.